AGT’s CEO to Present at NobleCon13

Filed Under: News Releases

View: 1.27.16 Press Release – NobleCon13

View: Noble Conference – Investor Presentation

View: Webcast

More AGT News Releases

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

The Cure Chronicles, an innovative video series launched by American Gene Technologies, is the winner of the third annual BioBuzz Media Award

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

The AGT Pipeline

AGT Corporate Profile

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!

American Gene Technologies

10 months ago

Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast!www.addimmune.com/jeff-galvin-explains-agts-innovative-approach-to-hiv-on-bio-blast/#genetherapy #biotech #innovation ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

12 months ago

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

1 years ago

M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

1 years ago

AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less

Photo

View on Facebook

AGT’s CEO to Present at NobleCon13

More AGT News Releases

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Get In Touch

American Gene Technologies Inc.

Contact Us

Investors

Pipeline

Technology

Media

About Us

More AGT News Releases

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Get In Touch

American Gene Technologies Inc.

Contact Us

Sign-up For Our Newsletter